$LPCN
Lipocine Inc.

2016 Q4 Form 10-K Financial Statement

#000114420418013981 Filed on March 12, 2018

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2016 Q2
Revenue $0.00 $0.00 $3.100K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.340M $1.390M $3.250M
YoY Change -30.57% -18.24% 190.18%
% of Gross Profit
Research & Development $1.330M $1.507M $2.570M
YoY Change -51.99% -68.17% -18.72%
% of Gross Profit
Depreciation & Amortization $10.00K $0.00 $10.00K
YoY Change 0.0% -100.0% 0.0%
% of Gross Profit
Operating Expenses $2.680M $3.286M $5.820M
YoY Change -42.98% -48.92% 36.05%
Operating Profit -$3.015M -$3.286M -$5.815M
YoY Change -35.8% -48.92% 35.94%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $50.00K $50.00K $60.00K
YoY Change -16.67% -16.67% 100.0%
Pretax Income -$2.970M -$3.235M -$5.760M
YoY Change -35.85% -49.23% 35.64%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.966M -$3.235M -$5.760M
YoY Change -35.98% -49.23% 35.65%
Net Earnings / Revenue -185810.03%
Basic Earnings Per Share -$0.16 -$0.18 -$0.32
Diluted Earnings Per Share -$0.16 -$0.18 -$0.32
COMMON SHARES
Basic Shares Outstanding 18.26M shares 18.25M shares 18.26M shares
Diluted Shares Outstanding 18.25M shares

Balance Sheet

Concept 2016 Q4 2016 Q3 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $26.84M $28.84M $32.94M
YoY Change -39.52% -30.99% -24.91%
Cash & Equivalents $5.561M $4.710M $12.37M
Short-Term Investments $21.28M $24.13M $20.57M
Other Short-Term Assets $330.0K $460.0K $150.0K
YoY Change -5.71% 31.43% -16.67%
Inventory
Prepaid Expenses
Receivables $40.00K $120.0K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $27.21M $29.41M $33.20M
YoY Change -39.37% -30.45% -24.8%
LONG-TERM ASSETS
Property, Plant & Equipment $100.0K $110.0K $120.0K
YoY Change 32.01% 32.68% 50.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Other Assets $30.75K $30.00K $30.00K
YoY Change 29.47% 26.3% 26.3%
Total Long-Term Assets $131.2K $140.0K $150.0K
YoY Change -73.74% -97.72% -98.45%
TOTAL ASSETS
Total Short-Term Assets $27.21M $29.41M $33.20M
Total Long-Term Assets $131.2K $140.0K $150.0K
Total Assets $27.34M $29.55M $33.35M
YoY Change -39.75% -38.98% -38.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $250.0K $860.0K $990.0K
YoY Change -50.7% 86.96% 148.23%
Accrued Expenses $1.080M $710.0K $1.600M
YoY Change -62.55% -58.72% 26.36%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.330M $1.570M $2.580M
YoY Change -60.79% -27.95% 54.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.330M $1.570M $2.580M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.330M $1.570M $2.580M
YoY Change -60.79% -27.95% 54.49%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.846K
YoY Change 1.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 5.710K shares 5.710K shares 5.710K shares
Shareholders Equity $26.02M $27.98M $30.76M
YoY Change
Total Liabilities & Shareholders Equity $27.34M $29.55M $33.35M
YoY Change -39.75% -38.98% -38.01%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2016 Q2
OPERATING ACTIVITIES
Net Income -$2.966M -$3.235M -$5.760M
YoY Change -35.98% -49.23% 35.65%
Depreciation, Depletion And Amortization $10.00K $0.00 $10.00K
YoY Change 0.0% -100.0% 0.0%
Cash From Operating Activities -$2.550M -$4.040M -$5.180M
YoY Change -12.67% -27.21% 34.2%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$20.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $2.830M -$3.620M $3.460M
YoY Change -380.2% -59.1% -122.87%
Cash From Investing Activities $2.830M -$3.620M $3.440M
YoY Change -380.2% -59.19% -122.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 580.0K 0.000 0.000
YoY Change -100.0% -100.0%
NET CHANGE
Cash From Operating Activities -2.550M -4.040M -5.180M
Cash From Investing Activities 2.830M -3.620M 3.440M
Cash From Financing Activities 580.0K 0.000 0.000
Net Change In Cash 860.0K -7.660M -1.740M
YoY Change -121.88% -46.66% -112.86%
FREE CASH FLOW
Cash From Operating Activities -$2.550M -$4.040M -$5.180M
Capital Expenditures $0.00 $0.00 -$20.00K
Free Cash Flow -$2.550M -$4.040M -$5.160M
YoY Change -12.67% -26.94% 33.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
752 USD
CY2015 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
16470814 shares
CY2016 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18258149 shares
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8076053 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5801823 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
19186834 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-18382068 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-19186834 USD
CY2015 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
173890 USD
CY2016 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
216078 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18208178 USD
CY2016 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-18970756 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
200 USD
CY2015 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.11
CY2016 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.04
CY2015 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
16470814 shares
CY2016 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
18258149 shares
CY2015 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18241278 USD
CY2016 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
24407 USD
CY2015 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32900 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-18971508 USD
CY2017 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10213695 USD
CY2017 us-gaap Operating Expenses
OperatingExpenses
21217976 USD
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-21217976 USD
CY2017 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
235816 USD
CY2017 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20982160 USD
CY2017 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
700 USD
CY2017 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20051934 shares
CY2017 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20978983 USD
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-20982860 USD
CY2017 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2016 us-gaap Restructuring Charges
RestructuringCharges
728635 USD
CY2015 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1150418 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2372615 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
276994 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
605870 USD
CY2015 lpcn Vesting Of Restricted Stock Awards Value
VestingOfRestrictedStockAwardsValue
0 USD
CY2016 lpcn Vesting Of Restricted Stock Awards Value
VestingOfRestrictedStockAwardsValue
0 USD
CY2015 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
32439313 USD
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2716142 USD
CY2017 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
581145 USD
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26721 USD
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
31960 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
1150418 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
2372615 USD
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
120248 USD
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-20612 USD
CY2015 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
200791 USD
CY2016 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-261152 USD
CY2015 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1557538 USD
CY2016 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1804540 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15356304 USD
CY2016 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18281938 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28689 USD
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
59650 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25018399 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3229125 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
276994 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
605870 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
32716307 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
605870 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7658396 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-14446943 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
27666055 USD
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20007659 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32439313 USD
CY2016 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-105593 USD
CY2015 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
144536 USD
CY2016 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
25272225 USD
CY2015 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
25789710 USD
CY2015 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
-32900 USD
CY2016 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
24407 USD
CY2016 us-gaap Accretion Expense
AccretionExpense
224482 USD
CY2015 us-gaap Accretion Expense
AccretionExpense
181390 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
28568000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
800000 USD
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28370 USD
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
2716142 USD
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
78679 USD
CY2017 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
352155 USD
CY2017 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
416802 USD
CY2017 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-16702015 USD
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 USD
CY2017 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3126020 USD
CY2017 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
581145 USD
CY2017 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11226028 USD
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2349967 USD
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2017 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-15876 USD
CY2017 us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
33055980 USD
CY2017 us-gaap Available For Sale Securities Change In Net Unrealized Holding Gain Loss Net Of Tax
AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLossNetOfTax
3877 USD
CY2017 us-gaap Accretion Expense
AccretionExpense
-99894 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
36182000 USD
CY2017Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2200000 USD
CY2016Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2900000 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0176 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0163 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8426 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.8139 pure
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0213 pure
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2800000 USD
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y14D
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.45
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.06
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.60
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18971508 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18208378 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-18971508 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-20982860 USD
CY2017 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-20982860 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
18261937 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
18257321 USD
CY2017 us-gaap Payments For Restructuring
PaymentsForRestructuring
239573 USD
CY2017Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1048932 USD
CY2016Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
1048932 USD
CY2017Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
103857 USD
CY2016Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
103857 USD
CY2017Q4 lpcn Computer Equipment And Capitalized Computer Software Gross
ComputerEquipmentAndCapitalizedComputerSoftwareGross
43361 USD
CY2016Q4 lpcn Computer Equipment And Capitalized Computer Software Gross
ComputerEquipmentAndCapitalizedComputerSoftwareGross
43361 USD
CY2017 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2016 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2015 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
0 USD
CY2017 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
700 USD
CY2016 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
752 USD
CY2015 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
200 USD
CY2017 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6450075 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-6190781 USD
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6709591 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6691992 USD
CY2016 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
6347 USD
CY2015 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
4697 USD
CY2016 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
496 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
102221 USD
CY2016 lpcn Income Tax Reconciliation Orphan Drug Tax Credits
IncomeTaxReconciliationOrphanDrugTaxCredits
127641 USD
CY2015 lpcn Income Tax Reconciliation Orphan Drug Tax Credits
IncomeTaxReconciliationOrphanDrugTaxCredits
155452 USD
CY2016 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
337968 USD
CY2015 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
452609 USD
CY2017 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-7133934 USD
CY2017 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-6173708 USD
CY2017 us-gaap Income Tax Reconciliation Other Reconciling Items
IncomeTaxReconciliationOtherReconcilingItems
4263 USD
CY2017 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
462 USD
CY2017 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
684854 USD
CY2017 lpcn Income Tax Reconciliation Orphan Drug Tax Credits
IncomeTaxReconciliationOrphanDrugTaxCredits
227109 USD
CY2017 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
394470 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1330706 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
1924260 USD
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
25395518 USD
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards State And Local
DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
30700358 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
54729 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
69112 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
3012081 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2465893 USD
CY2017Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
104 USD
CY2016Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Other
DeferredTaxAssetsTaxCreditCarryforwardsOther
70231 USD
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
30816428 USD
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
35909039 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
30813270 USD
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
35904927 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
3158 USD
CY2016Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
4112 USD
CY2017Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
3158 USD
CY2016Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
4112 USD
CY2017Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3158 USD
CY2016Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
4112 USD
CY2017Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2016Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2017Q4 lpcn Deferred Tax Assets Orphan Drug Tax Credit
DeferredTaxAssetsOrphanDrugTaxCredit
1023290 USD
CY2016Q4 lpcn Deferred Tax Assets Orphan Drug Tax Credit
DeferredTaxAssetsOrphanDrugTaxCredit
679185 USD
CY2017 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
5100000 USD
CY2016 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
7700000 USD
CY2017 lpcn Operating Loss Carry Forwards Limitations On Use Amount
OperatingLossCarryForwardsLimitationsOnUseAmount
1100000 USD
CY2017 lpcn Operating Loss Forgive Pre Ownership Change Amount
OperatingLossForgivePreOwnershipChangeAmount
5500000 USD
CY2017Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
96500000 USD
CY2017Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
2000000 USD
CY2016Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2015Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
58903 USD
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
58903 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
295000 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
374000 USD
CY2017 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
379000 USD
CY2015Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
63.96
CY2017 lpcn Class Of Warrant Or Right Redemption Price Of Warrants Or Rights
ClassOfWarrantOrRightRedemptionPriceOfWarrantsOrRights
0.001
CY2017 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2018-11-12
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
216000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
658000 USD
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
223000 USD
CY2017 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1 pure
CY2016 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
128000 USD
CY2015 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
74000 USD
CY2017 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
82000 USD
CY2013Q3 lpcn Maximum Proceeds From Affiliates Under License Agreement
MaximumProceedsFromAffiliatesUnderLicenseAgreement
10000000 USD
CY2013Q3 lpcn Percentage Of Fee To Be Received
PercentageOfFeeToBeReceived
0.2 pure
CY2015Q1 lpcn Service Fee
ServiceFee
230 USD
CY2016 lpcn Proceeds From Reimbursement
ProceedsFromReimbursement
3000 USD
CY2017 lpcn Proceeds From Reimbursement
ProceedsFromReimbursement
31000 USD
CY2015 lpcn Proceeds From Reimbursement
ProceedsFromReimbursement
61000 USD
CY2016Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7070404 USD
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5815120 USD
CY2016Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3286220 USD
CY2016Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-3015090 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-7009445 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-5760111 USD
CY2016Q3 us-gaap Net Income Loss
NetIncomeLoss
-3235485 USD
CY2016Q4 us-gaap Net Income Loss
NetIncomeLoss
-2966467 USD
CY2016Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.38
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.32
CY2016Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
CY2016Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2016Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.38
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.32
CY2016Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
CY2016Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2017Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4908915 USD
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6140618 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-4766059 USD
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-5402384 USD
CY2017Q1 us-gaap Net Income Loss
NetIncomeLoss
-4861260 USD
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-6089766 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
-4700248 USD
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-5331586 USD
CY2017Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
CY2017Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.31
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.25
CY2016Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2016Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2017Q4 us-gaap Common Stock Value
CommonStockValue
2127 USD
CY2016Q4 us-gaap Common Stock Value
CommonStockValue
1846 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1121080 USD
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1092710 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2016Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2016Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21270249 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
18462325 shares
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
21264539 shares
CY2016Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
18456615 shares
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5710 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
5710 shares
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
26359970 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
41985417 USD
CY2017 lpcn Vesting Of Restricted Stock Units Value
VestingOfRestrictedStockUnitsValue
0 USD
CY2017 us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
0 USD
CY2016 us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
7000 USD
CY2015 us-gaap Payments For Other Deposits
PaymentsForOtherDeposits
0 USD
CY2017 us-gaap Income Taxes Paid
IncomeTaxesPaid
700 USD
CY2016 us-gaap Income Taxes Paid
IncomeTaxesPaid
752 USD
CY2015 us-gaap Income Taxes Paid
IncomeTaxesPaid
200 USD
CY2016Q4 us-gaap Restructuring Reserve
RestructuringReserve
239573 USD
CY2017Q4 us-gaap Restructuring Reserve
RestructuringReserve
0 USD
CY2017 lpcn Description Of Terms Of Service Agreement
DescriptionOfTermsOfServiceAgreement
Under the service agreement, the Company provided facilities and up to 10 percent of the services of certain employees to Spriaso for a period of 18 months which expired
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1150418 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2372615 USD
CY2017 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2716142 USD
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M2D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
CY2017Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20429135 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
24200147 USD
CY2017 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
36200000 USD
CY2016 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
28600000 USD
CY2015 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
800000 USD
CY2017Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
18261937 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2017Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4616 USD
CY2017Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
18257321 USD
CY2016Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
21288063 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 USD
CY2016Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8493 USD
CY2016Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
21279570 USD
CY2017Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
18261937 USD
CY2017Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
18257321 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1196150 USD
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1196150 USD
CY2017 lpcn Stock Issued During Period Value Under At Market Offering
StockIssuedDuringPeriodValueUnderAtMarketOffering
10644883 USD
CY2017 lpcn Proceeds From Issuance Of Common Stock Through At Market Offering
ProceedsFromIssuanceOfCommonStockThroughAtMarketOffering
10644883 USD
CY2016 lpcn Proceeds From Issuance Of Common Stock Through At Market Offering
ProceedsFromIssuanceOfCommonStockThroughAtMarketOffering
0 USD
CY2015 lpcn Proceeds From Issuance Of Common Stock Through At Market Offering
ProceedsFromIssuanceOfCommonStockThroughAtMarketOffering
0 USD
CY2017 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
13240342 USD
CY2016 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 USD
CY2015 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
0 USD
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.34 pure
CY2017Q4 lpcn Common Stock Additional Amount Authorized
CommonStockAdditionalAmountAuthorized
25000000 USD
CY2017 lpcn Tax Credit Carryforward Pre Ownership Change Amount
TaxCreditCarryforwardPreOwnershipChangeAmount
1200000 USD
CY2017 lpcn Operating Loss Carry Forwards Preownership Change Amount
OperatingLossCarryForwardsPreownershipChangeAmount
20200000 USD
CY2017Q4 lpcn Common Stock Preferred Stock Debt Securities Warrants And Units To Be Sold Amount Maximum
CommonStockPreferredStockDebtSecuritiesWarrantsAndUnitsToBeSoldAmountMaximum
150000000 USD
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 0pt; FONT: 10pt Times New Roman, Times, Serif"> </div> <table style="BORDER-BOTTOM: 0px solid; BORDER-LEFT: 0px solid; MARGIN-TOP: 0pt; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0pt; BORDER-TOP: 0px solid; BORDER-RIGHT: 0px solid" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 24.45pt"> <div style="CLEAR:both;CLEAR: both"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></div> </td> <td style="WIDTH: 24.5pt"> <div style="CLEAR:both;CLEAR: both"><strong><i> (a)</i></strong></div> </td> <td> <div style="CLEAR:both;CLEAR: both"><strong><i>Use of Estimates</i></strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 48.95pt; FONT: 10pt Times New Roman, Times, Serif"> &#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px 0pt 48.95pt; FONT: 10pt Times New Roman, Times, Serif"> <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates and assumptions include those related to stock-based compensation; income tax uncertainties; and the useful lives of property and equipment</font>.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
3319927 USD
CY2016Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
0 USD
CY2017Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
4250000 USD
CY2016Q4 us-gaap Litigation Reserve Current
LitigationReserveCurrent
0 USD
CY2017 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
3319927 USD
CY2016 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
0 USD
CY2015 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
0 USD
CY2017 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
4250000 USD
CY2016 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
0 USD
CY2015 us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
0 USD

Files In Submission

Name View Source Status
0001144204-18-013981-index-headers.html Edgar Link pending
0001144204-18-013981-index.html Edgar Link pending
0001144204-18-013981.txt Edgar Link pending
0001144204-18-013981-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
lpcn-20171231.xml Edgar Link completed
lpcn-20171231.xsd Edgar Link pending
lpcn-20171231_cal.xml Edgar Link unprocessable
lpcn-20171231_def.xml Edgar Link unprocessable
lpcn-20171231_lab.xml Edgar Link unprocessable
lpcn-20171231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tv486805_10k.htm Edgar Link pending
tv486805_ex21-1.htm Edgar Link pending
tv486805_ex23-1.htm Edgar Link pending
tv486805_ex31-1.htm Edgar Link pending
tv486805_ex31-2.htm Edgar Link pending
tv486805_ex32-1.htm Edgar Link pending
tv486805_ex32-2.htm Edgar Link pending
tv486805_img1.jpg Edgar Link pending